The overall goal of this research is to define the cellular and, ultimately, the molecular bases for both currently recognized and yet to be defined primary immunodeficiency diseases, so as to provide the most rational and effective therapies for them. Correlative studies of lymphocyte phenotypes and function in patients with genetically-determined immuno-deficiency will provide clues to as yet undiscovered molecular derangements and also permit the discovery of atypical phenotypes resulting from known mutations. Most boys with SCID who have a high percentage of B cells and very low percentages of NK cells and low NK function will prove to have mutations in the gene encoding gamma-c, even though a majority will have a negative family history. Girls with this phenotype (or boys with this phenotype who do not have mutations in the gene encoding gamma-c) will prove to have Jak3 deficiency. SCID infants who express no gamma-c or Jak3 mRNA or protein will have more profound defects in B and NK cell function and will be clinically more severely affected than infants expressing gamma-c or Jak3 mRNA and proteins with amino acid substitutions. SCIDs who do not have gamma-c or Jak3 mutations will be studied for the presence of other known mutations, such as RAG1 or RAG2 deficiencies (ADA is usually excluded at the initial evaluation) or as yet unknown mutations, such as IL-7 or IL7R mutations. Studies of B cell isotype switching and immunoglobulin production with anti-CD40 monoclonal antibody plus IL-4 and other cytokines whose receptors do or do not share the gamma-c will contribute to the understanding of the nature of the B cell defect in severely antibody-deficient SCID's, as well as in other types of primary antibody deficiency diseases (such as non-X-linked Hyper IgM). Serial post-transplantation analyses of phenotypes, functions and genetic origins of lymphocytes in SCID recipients of haploidentical T cell-depleted parental marrow stem cells will reveal new information about T, B, and NK cell ontogeny not available in any other human experimental system.

Project Start
1999-12-01
Project End
2000-11-30
Budget Start
Budget End
Support Year
39
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Duke University
Department
Type
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Askie, Lisa M; Darlow, Brian A; Finer, Neil et al. (2018) Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration. JAMA 319:2190-2201
James, Jennifer; Munson, David; DeMauro, Sara B et al. (2017) Outcomes of Preterm Infants following Discussions about Withdrawal or Withholding of Life Support. J Pediatr 190:118-123.e4
Younge, Noelle; Goldstein, Ricki F; Bann, Carla M et al. (2017) Survival and Neurodevelopmental Outcomes among Periviable Infants. N Engl J Med 376:617-628
Srinivasan, Lakshmi; Page, Grier; Kirpalani, Haresh et al. (2017) Genome-wide association study of sepsis in extremely premature infants. Arch Dis Child Fetal Neonatal Ed 102:F439-F445
Denson, Lee A; McDonald, Scott A; Das, Abhik et al. (2017) Early Elevation in Interleukin-6 is Associated with Reduced Growth in Extremely Low Birth Weight Infants. Am J Perinatol 34:240-247
Archer, Stephanie Wilson; Carlo, Waldemar A; Truog, William E et al. (2016) Improving publication rates in a collaborative clinical trials research network. Semin Perinatol 40:410-417
Ahmed, Zuhayer; Prasad, Indrajit; Rahman, Hafizur et al. (2016) A Male with Extreme Subcutaneous Insulin Resistance: A Case Report. Rom J Diabetes Nutr Metab Dis 23:209-213
Phelps, Dale L; Ward, Robert M; Williams, Rick L et al. (2016) Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants. Pediatr Res 80:209-17
Barroso, Julie; Leserman, Jane; Harmon, James L et al. (2015) Fatigue in HIV-Infected People: A Three-Year Observational Study. J Pain Symptom Manage 50:69-79
Stafford-Smith, Mark; Li, Yi-Ju; Mathew, Joseph P et al. (2015) Genome-wide association study of acute kidney injury after coronary bypass graft surgery identifies susceptibility loci. Kidney Int 88:823-32

Showing the most recent 10 out of 128 publications